Cranbrook Wealth Management’s Lantern Pharma LTRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-717
Closed -$3.46K 290
2023
Q1
$3.46K Buy
+717
New +$3.46K ﹤0.01% 264